Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CORPUS CALLOSUM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | CORPUS CALLOSUM |
| Key Genes/Proteins | AKT, AMPK, APOE, CLU, MBP |
| Related Diseases | ALZHEIMER, ALZHEIMER'S DISEASE, APOPTOSIS, ASTROGLIOSIS, COGNITIVE DECLINE |
Knowledge base pages for this entity
graph TD
CORPUS_CALLOSUM["CORPUS CALLOSUM"]
CORPUS_CALLOSUM -->|"activates"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]
CORPUS_CALLOSUM -->|"activates"| WHITE_MATTER["WHITE MATTER"]
CORPUS_CALLOSUM -->|"activates"| MICROGLIA["MICROGLIA"]
NRF2["NRF2"] -->|"expressed in"| CORPUS_CALLOSUM
OXIDATIVE_STRESS -->|"expressed in"| CORPUS_CALLOSUM
AND["AND"] -->|"expressed in"| CORPUS_CALLOSUM
FERROPTOSIS["FERROPTOSIS"] -->|"expressed in"| CORPUS_CALLOSUM
MYELIN["MYELIN"] -->|"expressed in"| CORPUS_CALLOSUM
CX3CR1["CX3CR1"] -->|"expressed in"| CORPUS_CALLOSUM
MICROGLIA -->|"expressed in"| CORPUS_CALLOSUM
GENES["GENES"] -->|"expressed in"| CORPUS_CALLOSUM| Target | Relation | Type | Str |
|---|---|---|---|
| DEMYELINATION | activates | phenotype | 0.65 |
| MOG | associated_with | gene | 0.50 |
| COGNITIVE DECLINE | associated_with | phenotype | 0.50 |
| APOE | associated_with | gene | 0.50 |
| ALZHEIMER | associated_with | disease | 0.50 |
| MBP | associated_with | gene | 0.50 |
| CSF | associated_with | phenotype | 0.50 |
| DEMYELINATION | associated_with | phenotype | 0.50 |
| TNF | associated_with | gene | 0.45 |
| ASTROGLIOSIS | associated_with | phenotype | 0.45 |
| METFORMIN | associated_with | drug | 0.45 |
| APOPTOSIS | associated_with | phenotype | 0.45 |
| OLIG2 | associated_with | gene | 0.45 |
| AMPK | associated_with | gene | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
| TMEM106B | associated_with | gene | 0.45 |
| AKT | associated_with | gene | 0.45 |
| CLU | associated_with | gene | 0.45 |
| DOPAMINE | associated_with | phenotype | 0.45 |
| NEURON | associated_with | cell_type | 0.45 |
| OXIDATIVE STRESS | activates | process | 0.35 |
| WHITE MATTER | activates | brain_region | 0.35 |
| MICROGLIA | activates | cell_type | 0.35 |
| WHITE MATTER | regulates | brain_region | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ASTROGLIOSIS | interacts_with | phenotype | 0.65 |
| neuroinflammation | affects | disease | 0.60 |
| WHITE MATTER | treats | brain_region | 0.60 |
| COX6A2 | expressed_in | gene | 0.55 |
| NRF2 | expressed_in | gene | 0.55 |
| CX3CR1 | expressed_in | gene | 0.55 |
| CACNA1G | expressed_in | gene | 0.55 |
| ASXL1 | expressed_in | gene | 0.55 |
| Ferroptosis | associated_with | disease | 0.55 |
| SLC16A1 | expressed_in | gene | 0.55 |
| EPILEPSY | expressed_in | gene | 0.55 |
| MITOCHONDRIAL DYSFUNCTION | expressed_in | gene | 0.55 |
| OXIDATIVE STRESS | expressed_in | gene | 0.55 |
| AND | expressed_in | gene | 0.55 |
| FERROPTOSIS | expressed_in | gene | 0.55 |
| MYELIN | expressed_in | gene | 0.55 |
| MICROGLIA | expressed_in | gene | 0.55 |
| GENES | expressed_in | gene | 0.55 |
| RNA | expressed_in | gene | 0.55 |
| Ischemia | associated_with | disease | 0.50 |
| Fibroblast | expressed_in | cell_type | 0.50 |
| OLIGODENDROCYTES | associated_with | cell_type | 0.50 |
| OLIGODENDROCYTE | associated_with | cell_type | 0.50 |
| NEUROFILAMENT LIGHT | associated_with | biomarker | 0.50 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.50 |
| ALS | associated_with | disease | 0.50 |
| Aging | associated_with | disease | 0.50 |
| Epilepsy | associated_with | disease | 0.50 |
| Stem Cell | expressed_in | cell_type | 0.50 |
| MICROGLIAL ACTIVATION | associated_with | phenotype | 0.45 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.45 |
| BASAL GANGLIA | regulates | brain_region | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CORPUS CALLOSUM in their description or question text
No additional research found